Skip to main content
Top

Current Rheumatology Reports

Issue 6/2015

Content (7 Articles)

Orphan Diseases (B Manger, Section Editor)

Multicentric Reticulohistiocytosis: a Critical Review

Carlo Selmi, Adam Greenspan, Arthur Huntley, M. Eric Gershwin

Orphan Diseases (B Manger, Section Editor)

Tumor-Induced Osteomalacia: an Up-to-Date Review

Anke H. Hautmann, Matthias G. Hautmann, Oliver Kölbl, Wolfgang Herr, Martin Fleck

Health Economics and Quality of Life (M Harrison, Section Editor)

The Prediction and Monitoring of Toxicity Associated with Long-Term Systemic Glucocorticoid Therapy

Emma Harris, Ana Tiganescu, Sandy Tubeuf, Sarah Louise Mackie

Health Economics and Quality of Life (M Harrison, Section Editor)

How Important Is Mode of Administration in Treatments for Rheumatic Diseases and Related Conditions?

Nick Bansback, Logan Trenaman, Mark Harrison

Spondyloarthritis (MA Khan, Section Editor)

Looking Into the New ASAS Classification Criteria for Axial Spondyloarthritis Through the Other Side of the Glass

Nurullah Akkoc, Muhammad A. Khan

Spondyloarthritis (MA Khan, Section Editor)

Revisiting MHC Genes in Spondyloarthritis

Maxime Breban, Félicie Costantino, Claudine André, Gilles Chiocchia, Henri-Jean Garchon

PSORIATIC ARTHRITIS (O FITZGERALD AND P HELLIWELL, SECTION EDITORS)

Treat to Target in Psoriatic Arthritis—Evidence, Target, Research Agenda

Laura C. Coates, Philip S. Helliwell

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine